Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Stove

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 13, 2022
A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugsBram Bogaert, Félix Sauvage, Roberta Guagliardo, et al.
RSC Medicinal Chemistry|March 21, 2022
Structure-activity relationships of valine, <i>tert</i>-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICAEric Sparkes, Elizabeth A Cairns, Richard C Kevin, et al.
Nano Letters|March 13, 2024
Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA DeliveryBram Bogaert, Aliona Debisschop, Thomas Ehouarne, et al.
ACS Chemical Neuroscience|October 22, 2021
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?Adam Ametovski, Elizabeth A Cairns, Katharina Elisabeth Grafinger, et al.
Molecular Psychiatry|November 14, 2025
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodentsNúria Nadal-Gratacós, Pol Puigseslloses, Laura Guzmán, et al.
JACS Au|July 13, 2021
Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 PatientsBart Van Puyvelde, Katleen Van Uytfanghe, Olivier Tytgat, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 13, 2022
A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugsBram Bogaert, Félix Sauvage, Roberta Guagliardo, et al.
RSC Medicinal Chemistry|March 21, 2022
Structure-activity relationships of valine, <i>tert</i>-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICAEric Sparkes, Elizabeth A Cairns, Richard C Kevin, et al.
Nano Letters|March 13, 2024
Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA DeliveryBram Bogaert, Aliona Debisschop, Thomas Ehouarne, et al.
ACS Chemical Neuroscience|October 22, 2021
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?Adam Ametovski, Elizabeth A Cairns, Katharina Elisabeth Grafinger, et al.
Molecular Psychiatry|November 14, 2025
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodentsNúria Nadal-Gratacós, Pol Puigseslloses, Laura Guzmán, et al.
JACS Au|July 13, 2021
Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 PatientsBart Van Puyvelde, Katleen Van Uytfanghe, Olivier Tytgat, et al.
Pageof 9